CERADON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ceradon, and what generic alternatives are available?
Ceradon is a drug marketed by Takeda and is included in one NDA.
The generic ingredient in CERADON is cefotiam hydrochloride. There are two drug master file entries for this compound. Additional details are available on the cefotiam hydrochloride profile page.
Summary for CERADON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Patent Applications: | 817 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CERADON at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CERADON
US Patents and Regulatory Information for CERADON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda | CERADON | cefotiam hydrochloride | INJECTABLE;INJECTION | 050601-001 | Dec 30, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |